Overview

Celgene Pty Ltd is a foreign-owned private company, deriving revenue from the distribution and sale of biopharmaceutical products. The company employs approximately 70 people, operates in Australia and New Zealand, and is administered by its head office in Southbank, Victoria.

Celgene Pty Ltd is a wholly-owned subsidiary of Celgene Corporation, a US-based biotechnology company.

Celgene Pty Ltd researches and develops a variety of biopharmaceutical products primarily for the treatment of haematology and oncology-related diseases.  The products sold by the company to consumers and healthcare professionals are:

  • Istodax (Romidepsin)
  • Otezla (Apremilast)
  • Pomalyst (Pomalidomide)
  • Revlimid (Lenalidomide)
  • Thalomid (Thalidomide)
  • Vidaza (Azacitidine)

Celgene Pty Ltd also conducts clinical trials as part of its research into new drugs in Australia and New Zealand, with research and development conducted in Spain and the United States.

Learn more about our Company Reports

IBISWorld Company Profile Reports

Company profile reports provide key information on the Top 2000 earning companies in Australia. Reports include a written description of a company, its history, brands and products, contact details and key personnel, operating and legal structure, financial data, industries of involvement and business service providers.

Sample Data

This Company Has Operations in the Following Industries:

Pharmaceuticals Wholesaling in Australia

Table of Contents

Company Details
Key Personnel
Financials
Growth & Ratios
Segments
Shareholders
Subsidiaries
Service Providers

Looking for our Industry reports?

Assess your competitors with powerful business tools that provide strategic insights and analysis on over 600 Australian industries.

Contact Us

Want to speak to a representative? Call us.

clear